CCA Summit Live from IHPBA 2022

Videos — April 6, 2022

Featuring:

Flavio G. Rocha, MD, FACS, FSSO
Hedinger Chair of Surgical Oncology
Physician-in-Chief
Knight Cancer Institute
Oregon Health & Science University
Portland, OR

Flavio Rocha, MD, FACS, FSSO, the Hedinger Chair of Surgical Oncology and Physician-in-Chief of the Knight Cancer Institute at Oregon Health & Science University, presents an overview of the key abstracts on cholangiocarcinoma and gallbladder cancer presented at the 2022 annual meeting of IHPBA. Dr Rocha also provides his perspectives on the clinical impact of the data on patient outcomes.

Related Items

Surgical Management and Neoadjuvant Therapy for Cholangiocarcinoma
By Flavio G. Rocha, MD, FACS, FSSO
September 2022, Vol 3, No 3
Surgery remains the only potentially curative modality for cholangiocarcinoma (CCA) in any site of origin.
IHPBA Top Abstracts
June/July 2022, Vol 3, No 2
Dr Flavio Rocha, Chief of Surgical Oncology and Physician-in-Chief of the Knight Cancer Institute at Oregon Health & Science University, reviewed key abstracts on CCA and other biliary tract cancers presented at the IHPBA Congress.
Key Abstracts Presented at the Americas Hepato-Pancreato-Biliary Association (AHPBA) 2021 Annual Meeting
By Flavio G. Rocha, MD, FACS, FSSO
Videos
Flavio G. Rocha, MD, FACS, FSSO, from the Knight Cancer Institute, Oregon Health & Science University, provides expert commentary on key abstracts and posters presented at the 2021 annual meeting of the Americas Hepato-Pancreato-Biliary Association. Dr Rocha will highlight new data from 10 presentations on interventional modalities for patients with cholangiocarcinoma.

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: